Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India
Read more

Sun Pharma is Great Place To Work® Certified in India

Read More

Financial Results

Q3 FY23 Financial Results
READ MORE


Press Releases

Q3 FY23 Financial Press Release
Read More

COVID-19 Response

We are committed to ensure uninterrupted supply of medicines to support the Covid-19 pandemic response

Read more

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

Subscribe on YouTube

Sun Pharma on Twitter

Retweet on Twitter Sun Pharma Retweeted
Invest Punjab @invest_punjab ·
25 Jan 1618168972888903681

PSIP Dilip Kumar, CEO PBIP Kamal Kishor Yadav, & ACEO PBIP Himanshu Jain held detailed interaction with Dr. Dilip Shanghvi, MD @SunPharma_Live, and invited him to Progressive Punjab Investors' Summit 2023.

#InvestPunjab

@PunjabGovtIndia

Image for the Tweet beginning: PSIP Dilip Kumar, CEO PBIP Twitter feed image.
Image for the Tweet beginning: PSIP Dilip Kumar, CEO PBIP Twitter feed image.
Twitter 1618168972888903681
Sun Pharma @SunPharma_Live ·
2 Feb 1621042767110754306

Our MD, Dilip Shanghvi shares his views on India's Union Budget 2023-24.

Read more: https://bit.ly/3DyGRyF

Image for the Tweet beginning: Our MD, Dilip Shanghvi shares Twitter feed image.
Twitter 1621042767110754306
Sun Pharma @SunPharma_Live ·
31 Jan 1620417658675138564

We have announced our Q3, FY 23 results.

Read more: https://bit.ly/3wFKejN

Image for the Tweet beginning: We have announced our Q3, Twitter feed image.
Twitter 1620417658675138564
Sun Pharma @SunPharma_Live ·
31 Jan 1620376114547032064

Our Managing Director, Dilip Shanghvi provides an overview of our Q3, FY 23 results.

Image for the Tweet beginning: Our Managing Director, Dilip Shanghvi Twitter feed image.
Twitter 1620376114547032064
Sun Pharma @SunPharma_Live ·
30 Jan 1620015880192278528

Sun Pharma acquires Disperzyme® and Phlogam® brands to strengthen its anti-inflammatory portfolio

Read more: https://bit.ly/40aV4f5

Image for the Tweet beginning: Sun Pharma acquires Disperzyme® and Twitter feed image.
Twitter 1620015880192278528
Sun Pharma @SunPharma_Live ·
27 Jan 1618943467476099073

Become a part of our ever-growing community
Follow us now on LinkedIn!

https://www.linkedin.com/company/484735/admin/

Image for the Tweet beginning: Become a part of our Twitter feed video.
Twitter 1618943467476099073
Sun Pharma @SunPharma_Live ·
26 Jan 1618457817576538118

Sun Pharma wishes a happy Republic Day to all Indians! 🇮🇳
Let us unite and keep working towards making the world a healthier & happier place.
#Republicday #HappyRepublicday #Republicday2023

Image for the Tweet beginning: Sun Pharma wishes a happy Twitter feed image.
Twitter 1618457817576538118
Sun Pharma @SunPharma_Live ·
25 Jan 1618322416966701056

We are excited to announce the U.S. launch of the first and only FDA-approved product for treating neonatal seizures in term and preterm infants.

Learn more: http://bit.ly/406DNno

Image for the Tweet beginning: We are excited to announce Twitter feed image.
Twitter 1618322416966701056
Sun Pharma @SunPharma_Live ·
19 Jan 1616080510845071361

Sun Pharma announces signing of definitive agreement to acquire Concert Pharmaceuticals, Inc., adding a late-stage potential best-in-class treatment for patients with Alopecia Areata.

Learn More: https://bit.ly/3QRWMNZ

Image for the Tweet beginning: Sun Pharma announces signing of Twitter feed image.
Twitter 1616080510845071361
Sun Pharma @SunPharma_Live ·
11 Jan 1613094618136186881

Sun Pharma launches Palbociclib, a novel targeted therapy for advanced breast cancer with a unique Patient Assistance Program.

Read more : http://bit.ly/3WYwTym

Image for the Tweet beginning: Sun Pharma launches Palbociclib, a Twitter feed image.
Twitter 1613094618136186881
Follow us on Twitter

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Read more

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Read more

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Read more

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Read more
Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue
Top